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Calmodulin (CaM) is a ubiquitous 17kD Ca2+-binding protein found in all 
eukaryotic cells. It interacts with a wide variety of proteins and modulates their 
functions, playing essential roles in various cellular processes. In low intracellular 
Ca2+ concentration, Ca2+-free CaM (apoCaM) interacts with proteins containing IQ 
motif. GAP-43 (Neuromodulin) is a neuron specific growth-associated protein 
containing IQ-motif as its CaM-binding domain. It is considered to be a major 
determinant of synaptic development and plasticity, and has been implicated in 
molecular mechanisms underlying learning and memory. PKC phosphorylation has 
important effects on the interaction between CaM and GAP-43. In order to better 
understand the interaction between these two proteins through IQ motif, protein 
complex studies on Calmodulin – GAP-43 (Neuromodulin) was performed. 
CaM and a GAP-43 truncate (GAP-43t) were overexpressed and purified. 
Protein complex of apoCaM and GAP-43t was obtained by GTA (glutaraldehyde) 
crosslinking and identified by SDS-PAGE analysis. This protein complex provides a 
new approach to the studies on both the CaM – GAP-43 interaction and the apoCaM – 
IQ motif interaction. Further studies on the apoCaM – GAP-43t protein complex will 
provide significant insights into both interactions. 
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1.1 Calmodulin (CaM) 
CaM is a ubiquitous 17kD Ca2+-binding protein found in all eukaryotic cells 
(Chao et al. 1996; Cui et al. 2003). The protein sequence of CaM is highly conserved 
and identical among vertebrates (Bahler et al. 2002). 
 
1.1.1 CaM functions 
CaM interacts with a wide variety of proteins and modulates their functions, 
playing essential roles in various cellular processes (Houdusse et al. 1996; Cui et al. 
2003). The target proteins of CaM include protein kinases, ion transporter, and 
cytoskeletal elements, thus CaM can regulate such process as glycogen catabolism, 
smooth muscle contraction, neurotransmitter release, and cytoskeletal organization 
(Vogel 1994; Chao et al. 1996; Sellers 2000; Bahler et al. 2002). 
CaM is considered as the most common Ca2+ switch in the cell (Houdusse et al. 
1996). The regulatory role of CaM is intimately connected with the intracellular 
concentration of Ca2+, a major cellular second messenger (Finn et al. 1995; Bahler et 
al. 2002). In a resting cell, the intracellular Ca2+ concentration is of the order of 
50-100 nM, but the level may transiently rise to 1-10 μM as a result of an external 
stimulus (Finn et al. 1995). In response to this transient changes in intracellular Ca2+ 
concentration, CaM binds to Ca2+ and undergoes a conformational change, which 
renders it active and ready to bind to and regulate the activity of hundreds of target 
proteins (Finn et al. 1995; Ishida et al. 2002; Cui et al. 2003; Vetter et al. 2003). 
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1.1.2 CaM structure 
CaM is a dumbbell-shaped molecule consisting of two lobes and a long α-helix 
connecting them. Each lobe comprises two homologous domains consisting of two 
helix-loop-helix Ca2+-binding sites, called EF-hands (Nakayama et al. 1994; Finn et al. 
1995; Houdusse et al. 1996). 
When the intracellular Ca2+ concentration is high, CaM binds to Ca2+, appearing 
in the form of Ca2+-CaM. When the intracellular Ca2+ concentration is low, CaM 
disassociates with Ca2+, appearing in the Ca2+-free form, i.e. apoCaM (Jurado et al. 
1999). The structure of Ca2+-CaM was extensively studied by both NMR spectroscopy 
(Ikura et al. 1990; Ikura et al. 1991; Barbato et al. 1992) and x-ray crystallography 
(Cook et al. 1980; Babu et al. 1985; Kretsinger et al. 1986; Babu et al. 1988; Taylor et 
al. 1991; Chattopadhyaya et al. 1992; el-Sayed et al. 1995; Rupp et al. 1996; Wilson et 
al. 2000). Although the crystal of apoCaM was not obtained yet, NMR spectroscopy 
gave high-resolution data on this protein (Finn et al. 1993; Kuboniwa et al. 1995; 
Zhang et al. 1995; Ishida et al. 2002).  
Comparison of the structures of Ca2+-CaM and apoCaM reveals that the overall 
structure and distribution of secondary structure elements is very similar in both 
molecules (Fig. 1). The major difference is a significant alteration of the relative 
orientation of the helices in each lobe (Potter et al. 1983; Ikura 1996). The relative 
angles between the helices in Ca2+-CaM range from 86°C to 116°C, while these 
angles in apoCaM range from 121°C to 144°C (Zhang et al. 1995). This difference 
results in different lobe conformations adopted by Ca2+-CaM and apoCaM. 
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 Fig. 1. Structure of Ca2+-CaM and apoCaM 
(Vetter et al. 2003) 
 
CaM is shown in blue;  
Ca2+ ions are shown as yellow spheres. 
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In Ca2+-CaM, both N-terminal lobe and C-terminal lobe adopt “open” 
conformation (Houdusse et al. 1996). This conformation is characterized by a large 
hydrophobic pocket on the surface of each lobe. The hydrophobic pocket is formed by 
the exposure of several hydrophobic residues to the solvent, and acts as the anchor 
point of key residues in target molecule (Meador et al. 1992; Meador et al. 1993; 
Osawa et al. 1999). In apoCaM, both lobes adopted “closed” conformation, where the 
hydrophobic pocket is absent (Houdusse et al. 1996). However, a “semi-open” 
conformation was proposed to be adopted only by the C-terminal lobe of apoCaM 
when it binds to target peptide containing IQ motif (Houdusse et al. 1996). Compared 
to the open conformation, the “semi-open” conformation has a shallower hydrophobic 
pocket. Therefore, the lobe tips, instead of the lobe interior, interact strongly and 
specifically with the target (Houdusse et al. 1995; Houdusse et al. 1996). 
 
1.1.3 CaM interaction with target 
 
1.1.3.1 Ca2+-CaM-target interaction 
Ca2+-CaM binds to various proteins in high intracellular Ca2+ concentration, 
but the Ca2+-CaM-binding domain of these proteins lack apparent sequence 
similarities. The tertiary structures of Ca2+-CaM-target peptide complexes reveal a 
common sequence basis for target recognition of Ca2+-CaM (Meador et al. 1992; 
Meador et al. 1993; Osawa et al. 1999). The target peptides often possess a region 
that is characterized by a basic, amphipathic helix with two critical hydrophobic 
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residues at specific relative positions (1-10, 1-14 or 1-16). (Rhoads et al. 1997; Yap et 
al. 2000; Bahler et al. 2002; Yamauchi et al. 2003). Ca2+-CaM binds to the target 
peptides by encasing the helix between its two lobes. Each hydrophobic pocket in the 
N-terminal and C-terminal lobes of Ca2+-CaM grabs a critical hydrophobic residue. 
Fig. 2A shows a classic structure of Ca2+-CaM-target peptide complex. In this 
complex, the Ca2+-CaM-binding motif of CaMKII (Ca2+-CaM kinase II) is “1-10”. 
However, a distinct binding mode occurred in the crystal structure of protein 
complex of Ca2+-CaM and a MARCKS (myristoylated alanine-rich C kinase substrate) 
peptide (Fig. 2B). In this complex, the MARCKS peptide was highly elongated with a 
short helical region. The two hydrophobic residues that anchor the MARCKS peptide 
to N-terminal and C-terminal lobes of Ca2+-CaM, Phe157 and Leu159, were separated 
by only one residue. Only the C-terminal lobe of Ca2+-CaM created the conventional 
hydrophobic pocket. In the N-terminal lobe, helix D was shifted slightly and narrowed 
the cavity of the hydrophobic pocket. In conjunction with the shift, the 
pocket-oriented alkyl side chains of Met71 and Lys75, located on helix D, mask the 
pocket. Thus, the hydrophobic pocket was absent, and the hydrophobic surface was 
engaged in the interaction (Yamauchi et al. 2003). 
There are several Ca2+-CaM-binding proteins with sequence characteristics 
similar to MARCKS. The alignment of these proteins identifies two or more 
hydrophobic residues separated by short spacing. Therefore, these proteins may have 




Ca2+-CaM - MARCKS Ca2+-CaM - CaMKII
B 
Fig. 2. Structure of Ca2+-CaM-target peptide complex 
(Yamauchi et al. 2003) 
 
A: Protein complex of Ca2+-CaM and CaMKII peptide; 
B: Protein complex of Ca2+-CaM and MARCKS peptide. 
 
The N- terminal lobe of CaM is shown in green;  
The C- terminal lobe of CaM is shown in blue;  
The target peptides are shown in red;  
Ca2+ ions are shown as black spheres. 
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1.1.3.2 ApoCaM-target interaction through IQ motif 
In the absence or very low intracellular concentration of Ca2+, apoCaM binds 
to, and regulates a variety of proteins through a specific apoCaM-binding domain, IQ 
motif (Houdusse et al. 1996; Bahler et al. 2002; Cui et al. 2003; Putkey et al. 2003).  
IQ motif is a special sequence of about 25 residues. The core consensus 
sequence has the form “IQXXXRGXXXR” (where X is any amino acid) (Chao et al. 
1996; Houdusse et al. 1996; Bahler et al. 2002). Generally, position 1 is ambiguous for 
Ile, Leu or Val (Deloulme et al. 1997); position 11 can be either Arg or Lys; and 
position 7 is ambiguous for several residues. Thus, the sequence 
[I,L,V]QXXXRXXXX[R,K] represents a more generalized IQ motif (Bahler et al. 
2002).  
IQ motif is widely distributed in many proteins (Table 1) including myosins, 
neuronal growth proteins, voltage-operated channels, phosphatases, Ras exchange 
proteins, sperm surface proteins, a Ras Gap-like protein, spindle-associated proteins 
and several proteins in plants (Bahler et al. 2002). Among these proteins, GAP-43 
(Neuromodulin) and Neurogranin only have one IQ motif (Baudier et al. 1991), while 
Drosophila NinaC has two (Porter et al. 1993), Drosophilar igloo has three (Neel et 
al. 1994), brush-border myosin has four (Cheney et al. 1992), and several 
unconventional myosins, including the mouse dilute gene product (Cheney et al. 
1992), p190 in vertebrate brain (Espreafico et al. 1992), and Saccharomyces 
cerevisiae Myo2 (Cheney et al. 1992), have six IQ motifs. 
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Table 1. IQ motif in various proteins (Bahler et al. 2002)  
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Generally, IQ motif binds to apoCaM in the absence or very low intracellular 
concentration of Ca2+, and dissociates with it as the concentration of Ca2+ increases. 
However, interestingly, some IQ motif-containing proteins also bind to Ca2+-CaM in 
high intracellular concentration of Ca2+, showing dual affinity to CaM. These 
proteins include utrophin, Ras GRF1 (Ras guanine nucleotide-releasing factor), Nina 
C myosins, calcium vector target protein and others. In the case of Ras GRF1, Nina C 
and utrophin, the IQ motif also conforms to the Ca2+-CaM-binding “1-14” motif. In 
others the IQ motif may function in conjunction with a Ca2+-dependent motif (Bahler 
et al. 2002).  
In 1995, Urbauer et al. tried to study the interaction of apoCaM and a target 
peptide derived from bovine GAP-43 by NMR. But the peptide they used in the study 
(QASWRGHITRKKLKGEK) didn’t cover the core sequence of IQ motif because the 
critical residue Ile was missing. Two years later, Hayashi et al. (1997) made a same 
mistake. In their CD and NMR studies of the interaction of apoCaM and a target 
peptide derived from bovine GAP-43, they also used an incorrect peptide 
(QASFRGHITRKKLKGEK) which missed the critical residue Ile. It’s really a pity 
that their results couldn’t reliably contribute to the study of the interaction of apoCaM 
and target peptides through IQ motif. 
A theoretical model of apoCaM interaction with the IQ motif was constructed 
based on the high similarity between apoCaM and LC (light chain) of conventional 
myosin (Houdusse et al. 1996). In conventional myosin, LC binds to IQ 
motif-containing HC (heavy chain) of RD (regulatory domain). In unconventional 
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myosin, apoCaM instead binds to the IQ motif of HC. The sequences of CaM and the 
ELC (essential light chain) of scallop myosin exhibit 40% identity and 63% similarity 
(Houdusse et al. 1996). 
The crystal structure of the scallop myosin RD was obtained in 1995 
(Houdusse et al.). In this structure, when LC binds to HC, the C-terminal lobe of LC 
adopts a “semi-open” conformation, and interacts strongly and specifically with the 
special amphipathic target helix having the first part of the IQ motif core (IQXXXR). 
This is the most critical part of the motif that determines the lobe conformation of LC 
and also the position of LC on HC. The second part of the IQ motif core (GXXXR) 
plays a minor role in fixing the position of LC N-terminal lobe on HC and does not 
affect lobe conformation. 
The close sequence and structural homology between apoCaM and the ELC of 
scallop myosin provide a reliable basis for modeling a complex of apoCaM and an IQ 
motif peptide, using strict binding rules derived from the crystal structure of the 
scallop myosin RD. In this model (Fig. 3), two linker regions of apoCaM (linker 1 in 
the N-terminal lobe and linker 3 in the C-terminal lobe) were anchored to the target 
peptide. The C-terminal lobe adopts a “semi-open” conformation and interacts 
strongly with the critical first part of IQ motif core (IQXXXR). This strong interaction 
determines the lobe conformation and also the anchor position of linker 3. The 
N-terminal lobe adopts a “closed” conformation and interacts relatively weakly with 
the second half of the IQ motif core (GXXXR). This weak interaction helps to anchor 
linker1 and further stabilize the protein complex (Houdusse et al. 1996). 
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 Fig. 3. Theoretical model of apoCaM- IQ motif peptide complex 
(Houdusse et al. 1996) 
 
The helical IQ motif peptide is shown in black; 
The N-terminal lobe of apoCaM (domain I in red, domain II in yellow) 
adopts a closed conformation; 
The C-terminal lobe of CaM (domain III in cyan, domain IV in blue) 
adopts a semi-open conformation. 
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In 2003, Mori et al studied the binding of an IQ motif peptide with apoCaM 
C-terminal and N-terminal lobe fragments. The peptide used in this study, NaIQ 
(KRKQEEVSAIVIQRAYRRYLLKQKVKK), contains to the apoCaM-binding 
domain of rat voltage-gated sodium channel type II. The C-terminal and N-terminal 
lobe fragments of apoCaM were generated by trypsin-digestion of apoCaM. Their 
results showed that the NaIQ peptide interacted only with the C-terminal lobe 
fragment, but not with the N-terminal lobe fragment. This observation experimentally 
supports the theoretical model (Houdusse et al. 1996) that the C-terminal lobe of 
apoCaM adopts a “semi-open” conformation while the N-terminal lobe adopts a 
“closed” conformation when apoCaM binds to the IQ motif. 
In the same year, Cui et al (2003) performed NMR studies on the interaction 
between apoCaM and IQ motif of Neurogranin. The peptide they used was derived 
from the apoCaM-binding domain of bovine Neurogranin with the sequence of 
ANAAAAKIQASFRGHMARKKIKSG. Analysis of the binding of apoCaM with the 
IQ motif peptide showed the main interaction and conformation changes occurred in 
the C-terminal lobe of apoCaM. The linker1 (residues 40-44) in N-terminal lobe, 
linker 3 (residues 112-117) in C-terminal lobe, and the end of the α-helix H (residues 
145-148) in C-terminal lobe are involved in the binding. This result is consistent with 
the theoretical model (Houdusse et al. 1996). Furthermore, the calculated Kd of the 
interaction has an order of magnitude of 10-5 (1.2 x 10-5 to 8.8 x 10-5), which 
demonstrates that the interaction is a typical weak binding interaction. 
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1.2 GAP-43 (Neuromodulin) 
GAP-43 is a neuron specific growth-associated protein located at the 
presynaptic membrane. It’s a protein kinase C (PKC) substrate and can bind to 
apoCaM through its IQ motif (Sheu et al. 1990; Gamby et al. 1996; Benowitz et al. 
1997; Gerendasy 1999).  
The N-terminus 57 amino acids of GAP-43 are highly conserved across all 
vertebrates examined (Benowitz et al. 1997). The first ten amino acids, are crucial 
for the protein’s linkage to the nerve-terminal membrane (Zuber et al. 1989). The core 
sequence of its IQ motif, IQASFRGHITR, starts at the 38th residue (Alexander et al. 
1987; Chapman et al. 1991). In this IQ motif, Serine 41 is the unique phosphorylation 
site of PKC (Coggins et al. 1989; Chapman et al. 1991). 
 
1.2.1 GAP-43 and neuronal development and plasticity 
GAP-43 is considered as an intrinsic determinant of neuronal development 
and plasticity (Benowitz et al. 1997). In mammals, the expression of GAP-43 is 
restricted to the nervous system and is highest in the first week after birth 
(Biewenga et al. 1996). In the adult brain, GAP-43 is exclusively located at the 
presynaptic membrane with high plasticity (Gispen et al. 1991; Biewenga et al. 
1996). GAP-43 has been implicated in neuritogenesis during developmental stages 
of the nervous system and in regenerative processes and neuronal plasticity in the 
adult(Gispen et al. 1991).  
In transgenic mice, overexpression of high levels of an exogenous gene 
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encoding GAP-43 leads to the spontaneous formation of new synapses and aberrant 
connections, and also enhanced sprouting after injury. Even in the absence of 
additional trophic factors, GAP-43 enables neurons to sprout new terminals (Aigner 
et al. 1995). Null mutation of the GAP-43 gene disrupts the animal’s axonal 
pathfinding and is generally lethal shortly after birth (Strittmatter et al. 1995; 
Benowitz et al. 1997). 
In neuronal cell culture, GAP-43 is translocated to the growth cones during 
neuritogenesis (Gispen et al. 1991). Expression of GAP-43 in non-neuronal cells 
results in filopodial extensions (Biewenga et al. 1996). Conversely, suppressing 
GAP-43 expression has adverse effects on axon outgrowth. Primary sensory 
neurons from embryonic chick, when grown on poly-L-lysine, failed to extend 
axons when treated with antisense oligonucleotides complementary to portions of 
GAP-43 mRNA (Aigner et al. 1993). Antibodies to GAP-43 also prevented neurite 
outgrowth (Biewenga et al. 1996). 
In view of many positive correlations between GAP-43 expression and 
neurite outgrowth and the specific localization of GAP-43, one may conclude that 
GAP-43 plays a key role in guiding the growth of axons and modulating the 
formation of new connections. 
PKC phosphorylates GAP-43 on Ser41. This site can be dephosphorylated by 
Ca2+-independent phosphatases that are associated with the membrane (Han et al. 
1992) and by the soluble, Ca2+- and CaM-dependent phosphatase, calcineurin (Liu 
et al. 1989). The consequences of mutating Ser41 were examined. Substituting a 
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charged amino acid for Ser41 will mimic constitutive phosphorylation state, while 
substituting an uncharged amino acid for Ser41 will mimic the dephosphorylated 
state of the protein (Benowitz et al. 1997). Transgenic mice that overexpress the 
pseudo-phosphorylated GAP-43 show the same exuberant projections in the 
hippocampus and enhanced sprouting at the neuromuscular junction as animals 
that overexpress the wild-type protein; by contrast, transgenic animals 
overexpressing the dephosphorylated form of GAP-43 show much less sprouting 
(Aigner et al. 1995). Hence, phosphorylating GAP-43 on Ser41 appears to put cells 
in an activated state associated with growth and sprouting. 
 
1.2.2 GAP-43 phosphorylation and long-term potentiation (LTP) 
Long-term potentiation (LTP) is a well-known experimental model for 
studying the activity-dependent enhancement of synaptic plasticity. It’s also a 
system to investigate the molecular mechanisms of learning and memory. 
GAP43 has been implicated in molecular mechanisms underlying learning 
and memory. Genetic overexpression of GAP43 dramatically enhanced learning 
and LTP in transgenic mice. However, if the overexpressed GAP-43 was mutated 
by a Ser-Ala substitution to preclude its phosphorylation by PKC, then no learning 
enhancement was found (Routtenberg et al. 2000). The phosphorylation of 
GAP-43 was found to increase with the induction of LTP in the rat hippocampus 
by high frequency stimulation and correlate with the magnitude and duration of 
LTP-induced plasticity (Lovinger et al. 1986; Lovinger et al. 1987; Linden et al. 
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1989; Colley et al. 1990; Sheu et al. 1993). This increase was not detected after a 
control stimulation (Leahy et al. 1993). The NMDA-receptor antagonist  
D-2-amino-5-phosphonovalerate (APV), which blocks postsynaptic events that 
trigger LTP, prevented the increase in GAP-43 phosphorylation (Linden et al. 
1988; Ramakers et al. 1995).  
These findings provide evidence that expression of GAP-43 regulates 
learning and memory, and suggest the state of the GAP-43 phosphorylation site 
Ser41 regulates the level of LTP enhancement. This phosphorylation event is a 
critical one for learning and subsequent retention (Benowitz et al. 1997; 
Routtenberg et al. 2000). 
 
1.2.3 GAP-43 interaction with CaM through IQ motif 
GAP-43 can bind to CaM through its IQ motif. The affinity of CaM to 
GAP-43 is independent of intracellular Ca2+ concentration. In the absence of Ca2+, 
but not in its presence, CaM stabilizes an amphiphilic α-helical structure in 
GAP-43 (Gerendasy et al. 1995). Surprisingly, the N-terminal third of GAP-43 
alone binds to apoCaM more strongly than does intact GAP-43, suggesting that the 
protein's C-terminus may play a role in modulating the interaction with CaM 
(Chao et al. 1996). 
There is a PKC phosphorylation site, Ser41, in the CaM-binding IQ motif of 
GAP-43. PKC Phosphorylation on this site prevents CaM from binding to GAP-43 
(Alexander et al. 1987; Chapman et al. 1991; Chao et al. 1996); conversely, when 
 17
CaM is bound to GAP-43, PKC is inhibited from phosphorylating Ser41 (Sheu et 
al. 1995). Chao et al. (1996) changed Ser41 to Ala to produce a protein which 
could not be phosphorylated by PKC, and also changed Ser41 to Asp to mimic 
constitutive phosphorylation at this site. Substitution of Ala for Ser41 reduced the 
strength of the interaction between GAP-43 and CaM; substitution of Asp for 
Ser41 blocked the binding entirely. 
Fig. 4 shows the interaction between GAP-43 and CaM. In Fig. 4A, at low 
concentration of intracellular Ca2+, CaM binds to the IQ motif of GAP-43 and 
inhibits PKC from phosphorylating Ser41. Neither GAP-43 nor CaM exists in 
activated state. In Fig. 4B, with increasing levels of intracellular Ca2+, PKC 
becomes sufficiently activated to overcome the CaM block and phosphorylate 
Ser41. This leads to CaM dissociation with GAP-43 inhibits CaM from 
reassociating with GAP-43, allowing GAP-43 to remain in the activated state. In 
phosphorylation state, GAP-43 interacts with elements of the cytoskeleton, such as 
actin, to alter the motility of the nerve ending, thus affects the neuronal growth and 
plasticity. At the same time, free CaM binds to Ca2+ and becomes available to 
activate Ca2+-dependent target proteins and participate in various cellular 
processes. In this figure, CaM activation of calcineurin (CaN) is part of a feedback 
loop that ultimately leads to GAP-43 dephosphorylation. 
Since the effects of GAP-43 on neuronal growth and plasticity occur when 
the protein is phosphorylated and when no CaM is bound (Zuber et al. 1989; Chao 
et al. 1996), it seems that CaM binding serves to regulate the functions of GAP-43 
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(Benowitz et al. 1997). On the other hand, GAP-43 could serve as a CaM “sponge”, 
sequestering CaM at sites near the nerve-terminal membrane and releasing CaM in 
response to increased intracellular Ca2+ concentration that results from GAP-43 
phosphorylation (Skene 1989). The phosphorylation state of GAP-43 may regulate 
the local intracellular free CaM and Ca2+ concentrations or vice versa (Gispen et al. 
1991).  
 
1.3 Aim of the study 
In order to better understand the interaction between CaM and GAP-43 through 
IQ motif, we proposed the protein complex studies on CaM – GAP-43. We produced 
a GAP-43 truncate, GAP43t, as a substitute of GAP-43 to facilitate the formation of 
the protein complex. GAP43t contains the IQ motif as an apoCaM-binding domain 
and excludes the C-terminus of GAP-43, which may have an adverse effect on the 
apoCaM binding. 
The protein complex of apoCaM and GAP-43t represents not only a protein 
complex of CaM and a GAP-43 derived peptide, but also a protein complex of 
apoCaM and an IQ motif peptide. This protein complex provides a new approach 




Fig. 4. GAP-43 interaction with CaM 
(Benowitz et al. 1997) 
 
A: Low Ca2+ concentration; 




AA: arachidonic acid; 
CaN: calcineurin; 
DAG: diacylglycerol; 

























2.1 General Protocols 
 
2.1.1 Plasmid extraction from E.coli by Wizard Plus SV Minipreps DNA 
Purification System (Promega) 
1-10 ml overnight culture was pelleted for 5 min. Then the pellet was 
thoroughly resuspended with 250 μl Cell Resuspension Solution in a microcentrifuge 
tube. 250 μl Cell Lysis Solution was added and the tube was inverted 4 times to mix. 
10 μl Alkaline Protease Solution was added and the tube was inverted 4 times to mix. 
The mixture was incubated for 5 min at room temperature for cell lysis. 350 μl 
Neutralization Solution was added and the tube was inverted 4 times to mix. The 
mixture was centrifuged at top speed for 10 min at room temperature. 
The Spin Column was inserted into the Collection Tube. The cleared lysate 
from the centrifugation was decanted into the Spin Column for DNA binding. Then 
the tube was centrifuged at top speed for 1 min at room temperature. The 
flow-through was discarded and the Spin Column was reinserted into the Collection 
Tube. 
To wash, 750 μl Wash Solution (ethanol added) was added to the Spin Column. 
Then the tube was centrifuged at top speed for 1 min. The flow-through was discarded 
and the Spin Column was reinserted into the Collection Tube. The wash was repeated 
with 250 μl Wash Solution. Then the tube was centrifuged at top speed for 2 min at 
room temperature. 
The Spin Column was transferred to a sterile 1.5 ml microcentrifuge tube. 100 
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μl Nuclease-Free Water was added to the Spin Column. The tube was centrifuged at 
top speed for 1 min at room temperature for elution. 
 
2.1.2 PCR product purification by QIAquick PCR Purification Kit (QIAGEN) 
1 volume of the PCR sample was mixed with 5 volumes of Buffer PB. The 
QIAquick spin column was inserted into the collection tube. The mixture was 
decanted into the QIAquick spin column for DNA binding. Then the tube was 
centrifuged for 30-60 sec. The flow-through was discarded and the QIAquick spin 
column was reinserted into the collection tube.  
To wash, 0.75 ml Buffer PE was added to the QIAquick spin column. Then the 
tube was centrifuged for 30-60 sec. The flow-through was discarded and the 
QIAquick spin column was reinserted into the collection tube. The tube was 
centrifuged for an additional 1 min.  
The QIAquick spin column was transferred to a clean 1.5 ml microcentrifuge 
tube. 50 μl Buffer EB (10 mM Tris-Cl, pH 8.5) or H2O was added to the center of the 
QIAquick membrane. The tube was centrifuged for 1 min for elution. 
 
2.1.3 DNA fragment extraction from agarose gel by QIAquick Gel Extraction Kit 
(QIAGEN) 
The DNA fragment was excised from the agarose gel with a clean, sharp scalpel. 
The gel slice was weighed in a colorless tube. 3 volumes of Buffer QG was added to 1 
volume of gel (100 mg ~ 100 μl). Then the mixture was incubated at 50°C for 10 min 
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(or until the gel slice was completely dissolved). To help gel dissolve, the tube was 
vortexed every 2-3 min during the incubation.  
1 gel volume of isopropanol was added to the dissolved gel and mixed. The 
QIAquick spin column was inserted into the collection tube. The mixture was 
decanted into the QIAquick spin column for DNA binding. Then the tube was 
centrifuged for 1 min. The flow-through was discarded and the QIAquick spin column 
was reinserted into the collection tube. 0.5 ml Buffer QG was added to the QIAquick 
spin column. The tube was centrifuged for 1 min. 
To wash, 0.75 ml Buffer PE was added to the QIAquick spin column. Then the 
tube was centrifuged for 1 min. The flow-through was discarded and the QIAquick 
spin column was reinserted into the collection tube. The tube was centrifuged for an 
additional 1 min at 13,000 rpm (~17,900g). 
The QIAquick spin column was transferred to a clean 1.5 ml microcentrifuge 
tube. 50 μl Buffer EB (10 mM Tris-Cl, pH 8.5) or H2O was added to the center of the 
QIAquick membrane. The tube was centrifuged for 1 min for elution.  
 
2.1.4 E.coli competent cell preparation 
Frozen stock E.coli cells were thawed, streaked on fresh LB agar plate, and 
cultured overnight at 37°C.  
A single colony was inoculated into 10 ml LB and grown overnight with gentle 
shaking at 37°C. The overnight culture was subcultured 1:100 by inoculating 2.5 ml 
culture into 250 ml of LB supplemented with 20 mM MgSO4.  
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After OD600 reached 0.6, the cells were pelleted by centrifugation at 4,500 g for 
5 min at 4°C. The cell pellet was gently resuspended in 0.4 original volume of 
ice-cold TFB1 (30 mM KOAc, 100 mM RbCl2, 10 mM CaCl2, 50 mM MnCl2, 10% 
glycerol, pH5.8) and incubated on ice for 5 min. 
The cells were pelleted again by centrifugation at 4,500 g for 5 min at 4°C. The 
cell pellet was gently resuspended in 0.04 original volume of ice-cold TFB2 (10 mM 
MOPS, 75 mM CaCl2, 10 mM RbCl2, 15% glycerol, pH6.5) and incubated on ice for 
15-60 min.  
100 μl aliquot per tube was made and stored at -70°C. 
 
2.1.5 Transformation of plasmid to E.coli cells 
The frozen competent cells were thawed slowly on ice (~30 min). 200 µl of 
competent cells were added to 1-10 µl of DNA solution. The mixture was incubated 
on ice for 30 min. 
The mixture was heat-shocked in 42 °C water bath for 45 sec and returned to ice.  
0.8 ml of pre-warmed SOC was added. Then the mixture was incubated at 37 °C for 
60 min. 
The mixture was spread onto selective LB agar plate and incubated overnight at 
37°C. 
 
2.1.6 Protein quantification with Bradford assay 
The Protein Assay Dye Reagent Concentrate (Bio-Rad) was diluted to 20% with 
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water. BSA protein standards of 0.05 mg/ml, 0.1 mg/ml, 0.2 mg/ml, 0.3 mg/ml, 0.4 
mg/ml, and 0.5 mg/ml were prepared. 
10 µl of each standard and sample was added in triplicate into separate wells in a 
96-cell micro plate. Then 200 µl of diluted Dye Reagent was added to each well. 
Absorbance at 595 nm was read in a micro plate reader. A standard curve was 
drawn and the sample protein concentration was determined. 
 
2.1.7 Crystallization with hanging drop method 
1 ml of reservoir solution containing buffer and precipitants was dispensed into 
a reservoir well of the 24-well Linbro Plate (Hampton Research). High Vacuum 
Grease (Dow Corning) was applied on the rim of the well uniformly. 
1 µl of purified protein was placed on an Unbreakable Cover Slip (Fisher 
Scientific). Then 1 µl of reservoir solution was added to make a mixture drop. The 
cover slip was inverted and placed over the greased rim of the well. Then the cover 
slip was gently pressed from top to ensure perfect sealing of the well. 
The mixture drop on the cover slip was monitored with a microscope. 
 
2.2 Expression and purification of CaM 
 
2.2.1 Extraction of plasmid pET3a-CaM from E.coli DH5α 
2.2.2 Transformation of plasmid pET3a-CaM to E.coli BL21 
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2.2.3 Overexpression of CaM 
The E.coli BL21 cells containing pET3a-CaM plasmid were grown on LB plate 
containing 100 μg/ml Amp. A single colony of the above cells was inoculated into 50 
ml LB medium containing 100 μg/ml Amp. The cells were cultured at 37°C overnight.  
The initial culture was amplified to 1 L in same medium and cultured at 37°C. 
The culture growth was monitored until OD650 reached 0.7~ 0.8. 
When the culture reached OD650 0.7~0.8, IPTG was added to a final 
concentration of 0.5 mM. The cells were cultured at 37°C for 4-6 hours.  
 
2.2.4 Protein Extraction 
The cells were pelleted by centrifugation at 6,500 rpm, 4 °C for 10 min. Then 
the pellet was suspended in 100 ml cold lysis buffer (50 mM Tris, 2 mM EDTA, 1 
mM DTT, PH 7.5). 24 mg lysozyme was dissolved in 20 ml cool lysis buffer and 
added to the solution. The solution was stirred on ice for 40 min for cell lysis. 
1 M MgCl2 was added to the solution to a final concentration of 3 mM. 10 
mg/ml DNase store was added to a final concentration of 10 μg/ml. The solution was 
stirred on ice for 40 min.  
 The solution was centrifuged for 20 min at 13,000 rpm, 4 ºC. The supernatant 
was transferred to a clean centrifuge bottle and put on ice. The cold 50% (w/v) TCA 
was added to a final concentration of 3%. The solution was stirred on ice for 20 min. 
6 N NaOH was gradually added until the pH reached 5.3. 1/1000 volume of 0.5 M 
EDTA and 1/1000 volume of 0.1 M PMSF was added. The solution was stirred on ice 
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for 30 min to precipitate unwanted proteins. 
The solution was centrifuged for 10 min at 6,500 rpm, 4 ºC. The supernatant was 
transferred to a clean centrifuge bottle and put on ice. The cold 50% (w/v) TCA was 
added to a final concentration of 6%. The solution was stirred on ice for 10 min to 
precipitate CaM. 
The solution was centrifuged for 20 min at 6,500 rpm, 4 ºC. The pellet was 
dissolved on ice in 2 ml H2O, 1 ml 1 M Tris-base, and 6 ml 50 mM Tris-HCl, pH 7.5. 
 
2.2.5 FPLC Purification 
The HiLoad 26/10 Phenyl Sepharose High Performance column (Amersham 
Biosciences) was equilibrated with 2 bed volume of buffer A (50 mM Tris-HCl, 1 mM 
MgCl2, 1 mM CaCl2). The flow rate was 1 ml/ min. 1 M CaCl2 was added to the crude 
solution of CaM to a final concentration of 5 mM. 20 ml sample was loaded to the 
column with flow rate of 1 ml/min. 
Buffer A was used as running buffer with flow rate of 1 ml/min until OD280 was 
less than 0.05. Buffer B (50 mM Tris-HCl, 0.5 M NaCl, 1 mM MgCl2, 1 mM CaCl2) 
was used as running buffer with flow rate of 1 ml/min until OD280 was less than 0.01. 
Buffer C (50 mM Tris-HCl, 50 mM NaCl) was used as running buffer for 2 bed 
volume with flow rate of 1 ml/min. 
The fraction collector was connected and the collection was adjusted to 3 ml per 
fraction. CaM was eluted with buffer D (50 mM Tris-HCl, 50 mM NaCl, 1 mM 
EDTA). The flow rate was 1 ml/ min. Peak elution fractions were checked by 
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SDS-PAGE. Fractions containing CaM were pooled. 
 
2.3 Expression and purification of GAP-43 truncate (GAP-43t) 
 
2.3.1 Construction of plasmid pQE30-GAP43t 
7-8 weeks mouse brain was ground to fine powder in liquid nitrogen. Total RNA 
was extracted by Trizol Reagent (GIBCO BRL). The sample was lysed directly in a 
petri dish by adding 1 ml TRIzol Reagent, and passing the cell lysate several times 
through a pipette. The cell lysate was collected in a tube and incubated for 5 min at 
room temperature to permit the dissociation of nucleoprotein complexes. After adding 
0.2 ml chloroform, the tube was caped securely, shook vigorously by hand for 15 sec 
and incubated at room temperate for 3 min. Then the mixture was centrifuged at 
10,000 × g for 15 min at 4 ºC. After centrifugation, the mixture was separated into a 
lower red, phenol-chloroform phase, and a colorless upper aqueous phase. The 
aqueous phase was transferred to a fresh tube. Then the tube was added with 0.5 ml 
isopropyl alcohol, incubated at room temperature for 10 min, and centrifuged at 
10,000 g for 10 min at 4 ºC to precipitate the RNA. After removing supernatant, RNA 
pellet was washed the with 75% ethanol and centrifuged at 7,500 × g for 5 min at 4 ºC. 
Finally, RNA pellet was dried and then dissolved in RNase-free water. 
First-strand cDNA synthesis was performed with the SuperScript First-Strand 
Synthesis Kit (GIBCO BRL). The total RNA and primer mixtures were prepared in 
0.5 ml tubes, containing 2 µl total RNA, 1 µl 10 mM dNTP mix, 1 µl 0.5 µg/µl oligo 
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(dT) and DEPC-treated water. The samples were incubated at 65 ºC for 5 min to 
denature and were placed on ice for 5 min. Then the reaction mixture was prepared 
containing 2 µl 10 × RT buffer, 4 µl 25 mM MgCl2, 2 µl 0.1 M DTT and 1 µl 
RNaseOUT Recombinant RNase Inhibitor. 9 µl of reaction mixture was added to each 
RNA/primer mixture and incubated at 42 ºC for 2 min to anneal. 1 µl (50 units) of 
SuperScript II RT was added to each tube and incubated further at 42 ºC for 50 min to 
synthesize the cDNA. The reaction was terminated at 70 ºC for 15 min and chilled on 
ice. The reaction was collected by brief centrifugation, and 1 µl of RNaseH was added 
to each tube and incubated for 20 min at 37 ºC before proceeding to PCR. 
One pair of GAP-43 primers was designed according to mouse GAP-43 cDNA 
sequence in Gene Bank (NM_008083). 
Forward primer (GAP-43 A): 5’ ATGCTGTGCTGTATGAGAAGAAC 3’ 
Reverse Primer (GAP-43 B): 5’ TCAGGCATGTTCTTGGTCAG 3’ 
PCR was performed to obtain GAP-43 cDNA. 
PCR components (50 µl): 
first-strand cDNA from RT reaction     2 µl 
primer GAP-43 A         1 µl 
primer GAP-43 B         1 μl 
10mM dNTPs          1 µl 
Finzyme DNA polymerase       1 μl 
Finzyme DNA polymerase buffer     5 µl 
ddH2O            39 µl 
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PCR Program: 
Hold 1:  94ºC 2 min 
Hold 2:  30 cycles 
94ºC 30 sec 
58ºC 30 sec 
68ºC 1 min 
Hold 3:  68ºC 10 min 
PCR product was purified by QIAquick PCR Purification Kit.  
One pair of GAP-43t primers was designed to produce a 300bp GAP-43 cDNA 
truncate which encodes the first 100 residues of GAP-43 from N-terminal containing 
the IQ motif. 
Forward primer (GAP-43t/ Sac I): 5’ GTGAGCTCCTGTGCTGTATGAGA 3’ 
Reverse primer (GAP-43t/ Kpn I): 5’ GTGGTACCCTCAGCCTTGGGGCT 3’ 
PCR was performed to obtain the GAP-43 cDNA truncate. 
PCR components (25 µl): 
purified GAP-43 cDNA        1 µl 
primer GAP-43t/ Sac I        1 µl 
primer GAP-43t/ Kpn I        1 µl 
10mM dNTPs          0.5 µl 
Finzyme DNA polymerase       1 µl 
Finzyme DNA polymerase buffer     2.5 µl 
ddH2O            18 µl 
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PCR Program: 
Hold 1:  94ºC 3 min 
Hold 2:  10 cycles 
94ºC 30 sec 
58ºC 30 sec 
72ºC 1 min 
Hold 3:  30 cycles 
94ºC 30 sec 
62ºC 30 sec 
72ºC 1 min 
Hold 4:  72ºC 10 min 
PCR product was purified by QIAquick PCR Purification Kit. 
The purified GAP-43 cDNA truncate and the expression plasmid pQE30 
(QIAGEN) (Fig. 5) were digested by Sac I and Kpn I (New England Biolab) at 37 ºC 
overnight. The digestion products were electrophoresed on 1% agarose gel and DNA 
fragments were extracted from the gel by QIAquick Gel Extraction Kit. 
Ligation of GAP-43 cDNA truncate and linear pQE30 fragment was performed 
with T4 ligase (New England Biolab) at 16 ºC overnight. The ligation product was 
transformed to E.coli JM109. 
Plasmid pQE30-GAP43t was extracted from positive clones by Wizard Plus SV 
Minipreps DNA Purification System and verified by sequencing. 
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2.3.2 Transformation of plasmid pQE30-GAP43t to E.coli M15/pREP4 
2.3.3 Overexpression of GAP-43t 
A single colony of E.coli M15/pREP4 cells containing pQE30-GAP43t plasmid 
was inoculated into 5 ml LB medium containing 100 μg/ml Amp and 25 μg/ml Kan. 
The cells were cultured at 37°C for 9 hours. 
The initial culture was amplified to 250 ml in same medium and cultured 
overnight at 37°C. The overnight culture was amplified to 1 L in LB medium 
containing 100 μg/ml Amp and cultured at 37°C. The culture growth was monitored 
until OD650 reached 0.7~ 0.8. 
When the culture reached OD650 0.7~0.8, IPTG was added to a final 
concentration of 1 mM. The cells were cultured at 37°C for 5 hours. 
 
2.3.4 Purification of GAP-43t 
The cells were pelleted by centrifugation at 6,000 rpm, 4°C for 20 min. Then the 
pellet was suspended in cold lysis buffer (50 mM Tris pH 7.5, 0.3 M NaCl, 10 mM 
imidazole with 1 mM DTT and 1 tablet/40 ml EDTA free Roche protease inhibitor 
cocktail). The solution was stirred on ice for 40 min for cell lysis. 
20 ml slurry (50% beads) in Ni-NTA column was equilibrated with 2 CV lysis 
buffer. The crude lysate was centrifuged at 18,000rpm, 4°C for 20 min and the 
supernatant was loaded into the column. 
The column was washed with 4 CV wash buffer (50 mM Tris pH 7.5, 0.3 M 
NaCl, 20 mM imidazole) for 3 times. 
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GAP-43t was eluted with elution buffer 1 (50 mM Tris pH 7.5, 0.3 M NaCl, 0.3 
M imidazole) for 2 times and elution buffer 2 (50 mM Tris pH 7.5, 0.3 M NaCl, 0.4 M 
imidazole) for 4 times. The elutions were checked by SDS-PAGE. 
 
2.4 Crystallization of CaM 
CaM was concentrated to 6 mg/ml by YM-10 centricon (Millipore). 
Crystallization was performed with hanging drop method. JBScreen crystal screening 
kits 1-10 (Jena Bioscience) were used to screen the crystallization conditions. Each kit 
contains 24 different formulations which can be tested in a 24-well Linbro Plate 
(Hampton Research). Totally 240 formulations in these 10 kits were tested. 
Formulations of the kits are listed in Table 2. 
 
2.5 Crystallization of GAP-43t 
GAP-43t was concentrated to 6 mg/ml by YM-10 centricon (Millipore). 
Crystallization was performed with hanging drop method. JBScreen crystal screening 
kits 1-10 (Jena Bioscience) and Hampton Crystal Screen kit (Hampton Research) 
were used to screen the crystallization conditions.  Totally 240 formulations in 
JBScreen crystal screening kits 1-10 and 50 formulations in Hampton Crystal Screen 
kit were tested. Formulations of the kits are listed in Table 2 and Table 3. 
 
2.6 Binding of apoCaM and GAP-43t 
CaM was decalcified by adding 0.5 M EGTA to a final concentration of 50 mM. 
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Certain molar ratio of apoCaM and GAP-43t were mixed. EDTA was added to a final 
concentration of 5 mM. The mixture was incubated for 5 min at room temperature. 
1% GTA was added to a final concentration of 0.05%. The mixture was incubated on 
ice for certain time. SDS-PAGE was employed to check the protein complex of 
apoCaM and GAP-43t. 
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3.1 Expression and purification of CaM 
 
3.1.1 Overexpression of CaM under IPTG induction 
Plasmid pET3a-CaM was extracted from E.coli DH5α and transformed to E.coli 
BL21. CaM was overexpressed under IPTG induction. The induced overexpression 
was compared with non-induced control expression by SDS-PAGE (Fig. 6). The CaM 
concentration is much higher in IPTG induced overexpression than that in 
non-induced control expression, indicating the IPTG induction was effective and CaM 
was overexpressed.  
 
3.1.2 CaM purification by FPLC 
The E.coli BL21 cells that overexpressed CaM were lysed and total protein was 
extracted. Unwanted proteins were discarded and crude solution of CaM was obtained. 
CaM was purified by FPLC (Fig. 7). Peak elution fractions from FPLC were checked 
by SDS-PAGE (Fig. 8). Fractions containing CaM were pooled. Western Blot of 
purified CaM with anti-CaM antibody was applied to confirm (Fig. 9). The 
concentration of the purified CaM was determined to be 1 mg/ml by Bradford assay. 
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CaM 
   M     1     2      3     4     5      6 
25 kD 
Fig. 6. IPTG induced CaM overexpression 
 
M: Protein Molecular Weight Marker (Fermentas) 
Lane 1, 2, 4, 5: IPTG induced expression 































M          1          2         3 
21.5 kD 
Fig. 8. Purified CaM 
 
M: SDS-PAGE low molecular weight standards (Bio-Rad) 









1      2 
Fig. 9. Western Blot of purified CaM with anti-CaM antibody 
 
Lane 1: Purified CaM 
Lane 2: Negative control 
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3.2 Expression and purification of GAP-43 truncate (GAP-43t) 
 
3.2.1 Construction of plasmid pQE30-GAP43t 
Total RNA was extracted from 7-8 weeks mouse brain and GAP-43 cDNA was 
obtained by RT-PCR. Using the GAP-43 cDNA as a template, PCR was performed to 
produce a 300 bp GAP-43 cDNA truncate (Fig. 10) which encodes a truncate peptide 
of GAP-43, GAP43t. GAP43t corresponds to the first 100 residues of GAP-43 from 
N-terminal and contains the IQ motif as an apoCaM-binding domain. The GAP-43 
cDNA truncate was inserted into plasmid pQE30 (Fig. 5) which contains a 6xHis-Tag. 
The newly constructed plasmid pQE30-GAP43t (Fig. 11) was verified by DNA 
sequencing. 
 
3.2.2 Overexpression and purification of GAP-43t 
Plasmid pQE30-GAP43t was transformed to E.coli M15/pREP4 and GAP43t 
was overexpressed under IPTG induction. The E.coli M15/pREP4 cells that 
overexpressed GAP-43t were lysed and GAP-43t was purified by Ni-NTA column. 
The elutions were checked by SDS-PAGE (Fig. 12). After 6 elutions, purified 
GAP-43t was obtained.  
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1                     M 
GAP-43 cDNA 
truncate 300 bp 
Fig. 10. GAP-43 cDNA truncate 
 
M: GeneRuler™ 100bp DNA Ladder Plus (Fermentas) 






M            1 
Fig. 11. Plasmid pQE30-GAP43t 
 
M: GeneRuler™ 1 kb DNA Ladder (Fermentas) 































































































































3.3 Crystallization Studies 
 
3.3.1 Crystallization of CaM 
Crystallization of CaM was performed with hanging drop method. Totally 240 
formulations in JBScreen crystal screening kits 1-10 (Table 2) were used to screen the 
crystallization conditions. CaM crystals were obtained with the following conditions: 
Sample: 6 mg/ml CaM 
Reservoir solution: JBScreen 8, Formulation A3 (Table 2) 
Buffer: 100 mM Tris-HCl pH 8.5 
Precipitant: 50% MPD (2-methyl-2, 4-pentanediol) 
Additive: 200 mM Ammonium Dihydrogen Phosphate 
4 ºC, 4 days 
CaM crystals (Fig. 13) were singular and appeared in long thin needles. This is 
consistent with previous studies (Rupp et al. 1996). But the size and quality of these 
crystals were not satisfactory for X-ray diffraction. 
 
3.3.2 Crystallization of GAP-43t 
Crystallization of GAP-43t was performed with hanging drop method. Totally 
240 formulations in JBScreen crystal screening kits 1-10 (Table 2) and 50 
formulations in Hampton Crystal Screen kit (Table 3) were used to screen the 
crystallization conditions. No GAP-43t crystals were obtained with these conditions. 
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 Fig. 13. CaM crystals 
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3.4 Protein Complex of apoCaM and GAP-43t 
 
Protein complex of apoCaM and GAP-43t was obtained by GTA crosslinking. 
ApoCaM and GAP-43t were incubated together and GTA treatment was applied. In 
the subsequent SDS-PAGE analysis (Fig. 14, 15, 16), a 29kD new protein band was 
observed. The molecular weight of this new protein is equal to the sum of apoCaM 
(17kD) and GAP-43t (12kD), suggesting a protein complex was formed by apoCaM 
and GAP-43t with 1:1 molar ratio. 
In Fig. 14, different molar ratios of apoCaM and GAP-43t were incubated and 
treated with 0.05% GTA for 45 min. Lane 3, 4, and 5 show the molar ratio of 1:1, 1:5, 
and 1:3, respectively. The protein complex appeared in each molar ratio combination. 
In lane 3, 1:1 molar ratio of apoCaM and GAP-43t gave the highest yield of the 
protein complex and the least smear. While in lane 4 and 5, the molar ratio of 1:5 and 
1:3 resulted in heavy smears. The 3:1 molar ratio of apoCaM and GAP-43t was also 
tested and the result is shown in Fig. 16, lane 3, in comparison with 1:1 (Fig. 16, Lane 
1) and 1:5 (Fig. 16, Lane 2). Little smear was observed but the yield of the protein 
complex was low. These results indicate 1:1 molar ratio of apoCaM and GAP-43t is 
the best combination for the formation of the protein complex. 
In Fig. 15, 1:1 molar ratio of apoCaM and GAP-43t was incubated and treated 
with 0.05% GTA for different times. Lane 1, 2, 3, and 4 show the GTA treatment time 
of 75 min, 90 min, 105 min, and 120 min, respectively. The yield of the protein 
complex of apoCaM and GAP-43t was observed to increase with the increase of GTA 
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treatment time. This indicates the GTA crosslinking of apoCaM and GAP-43t acts in 
a time-dependent manner. However, obvious smears were observed in lane 4, 
suggesting GTA treatment longer than 120 min may result in heavy smears. These 
results were repeated in Fig. 16, lane 6-9. 
As a control experiment, apoCaM and GAP-43t were treated with 0.1% GTA for 
120 min separately. In Fig. 16, lane 4 shows the GTA treatment of apoCaM alone and 
no new band was observed. Lane 5 shows the GTA treatment of GAP-43t alone. 
Several new bands resulting from self-linkage of GAP-43t were observed but the 
29kD protein band was absent. These results exclude the possibility that the 29kD 
new protein resulted from self-linkage of apoCaM or GAP-43t. Therefore, the 29kD 
protein we obtained represents the protein complex of apoCaM and GAP-43t. 
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GAP-43t 
apoCaM 21.5 kD 
14.4 kD 
31 kD 
M      1      2      3      4       5 
Protein 
Complex
Fig. 14. Protein Complex of apoCaM and GAP-43t 
(0.05% GTA treatment for 45 min) 
 
M: SDS-PAGE low molecular weight standards (Bio-Rad) 
1: apoCaM 
2: GAP-43t 
3: apoCaM + GAP-43t (molar ratio 1:1) 
4: apoCaM + GAP-43t (molar ratio 1:5) 
5: apoCaM + GAP-43t (molar ratio 1:3) 
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Fig. 15. Protein Complex of apoCaM and GAP-43t 
(molar ratio 1:1) 
 
M: SDS-PAGE low molecular weight standards (Bio-Rad) 
1: apoCaM + GAP-43t (0.05% GTA treatment for 75 min) 
2: apoCaM + GAP-43t (0.05% GTA treatment for 90 min) 
3: apoCaM + GAP-43t (0.05% GTA treatment for 105 min) 







































































































































































































































































































GAP-43 can bind to apoCaM. The apoCaM-binding domain of GAP-43 is its IQ 
motif near the N-terminal (Benowitz et al. 1997). Previous study showed an 
N-terminal 93-residue truncate of GAP-43 (the N-terminal third of GAP-43) bound 
to apoCaM more strongly than did intact GAP-43 (Chao et al. 1996). This suggests 
that the C-terminus of GAP-43 may have an adverse effect on the binding of GAP-43 
and apoCaM. 
Based on the above findings, we expressed a truncate peptide of GAP-43, 
GAP-43t, which corresponds to the first 100 residues of GAP-43 from N-terminal. 
Similar to the N-terminal 93-residue truncate of GAP-43 used in previous study (Chao 
et al. 1996), GAP-43t contains the IQ motif to ensure its binding to apoCaM, and 
excludes the C-terminus of GAP-43 to eliminate the adverse effect on this binding. 
Therefore GAP-43t used in this study is an ideal substitute of GAP-43 to form a 
protein complex with apoCaM.  
 
4.2 Crystallization Studies 
Optimal conditions for protein crystallization are difficult to predict and usually 
thousands of conditions have to be tried to succeed. Screening is a highly effective 
and rapid tool for determining the initial crystallization conditions of biological 
macromolecules. Once crystals are obtained under certain condition, optimization of 
this condition will give crystals of larger size and better quality for X-ray diffraction. 
There are many commercial crystal screening kits available for screening the 
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protein crystallization conditions. The formulations in these kits come from the most 
successful conditions published for protein crystallization. The ready to use kits allow 
us to quickly test wide ranges of precipitants, buffers, pH, and additives using a very 
small volume of sample. In this study, JBScreen crystal screening kits 1-10 and 
Hampton Crystal Screen kit were used to screen the crystallization conditions of CaM 
and GAP-43t.  
For CaM, singular crystals appearing in long thin needles (Fig. 13) were obtained 
with Formulation A3 of JBScreen 8 (Table 2). Although the size and quality of these 
crystals were not satisfactory for X-ray diffraction, CaM crystals of larger size and 
better quality can be expected by optimizing this condition. For GAP-43t, no crystals 
were obtained after 290 formulations (Table 2 and Table 3) were tested. The failure 
may result from any inappropriate variable that influences the crystallization, such as 
precipitant, buffer, pH, or additive. More conditions have to be tried to obtain the 
GAP-43t crystals and conditions listed in Table 2 and Table 3 can be excluded from 
further attempts.  
 
4.3 GTA crosslinking 
GTA (glutaraldehyde) is a widely used protein crosslinker. It links covalently to 
the amine groups of lysine or hydroxylysine and generates covalent bonds between 
these residues located at the interface between the protein molecules (Landschulz et al. 
1989; Halvorsen et al. 1990). This crosslinking results in the stabilization of 
oligomeric forms of the protein molecules, which can be subsequently identified by 
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SDS-PAGE analysis (Malygin et al. 2001; Silva et al. 2004). Therefore GTA can be 
used for the stabilization of the protein complex of apoCaM and GAP-43t. 
Recent study (Silva et al. 2004) confirmed that the number of free lysine residues 
plays a key role in GTA crosslinking. In proteins with a high amount of free lysine 
residues, GTA crosslinking constitutes an effective way for the formation of 
multimers. In addition to the total number of lysine residues, the protein conformation, 
which determines the availability of lysine residues to GTA, also contributes to 
determine the number of free lysine residues (Silva et al. 2004). Therefore GTA 
crosslinking is regulated by both the total number of lysine residues and the 
conformation of the proteins involved.  
In this study, GTA was used for the stabilization of the protein complex of 
apoCaM and GAP-43t. After GTA treatment, the protein complex was obtained and 
identified by SDS-PAGE analysis (Fig. 14, 15, 16). However, the yield of the protein 
complex was not satisfactory, partially because the GTA crosslinking was affected by 
the low amount of free lysine residues in apoCaM. Totally there are only 8 lysine 
residues in the 149-residue CaM and the lysine content is only 5.37%. Moreover, in 
the protein complex with GAP-43t, apoCaM adopts a “closed” conformation in 
N-terminal lobe and a “semi-open” conformation in C-terminal lobe. Both 
conformations restrict the access of GTA to the lysine residues of apoCaM. The low 
amount of free lysine residues in apoCaM also inhibited the apoCaM self-linkage 
under GTA treatment (Fig. 16, Lane 4). On the other hand, GAP-43t has a very high 
content of lysine. There are total 17 lysine residues in this 100-residue peptide and the 
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lysine content is 17%. Although the conformation of GAP-43t is not clear, a high 
amount of free lysine residues in GAP-43t can be concluded from the serious 
self-linkage of GAP-43t under GTA treatment (Fig. 16, Lane 5). The high amount of 
free lysine residues in GAP-43t can enhance the GTA crosslinking between apoCaM 
and GAP-43t to stabilize the protein complex. But it also can increase the GAP-43t 
self-linkage, which may compete with the binding of apoCaM and GAP-43t, and 
affect the yield of the protein complex. 
 
4.4 Protein complex of apoCaM and GAP-43t 
 
Protein complex of apoCaM and GAP-43t was obtained by GTA crosslinking. 
The protein complex was identified by SDS-PAGE analysis (Fig. 14, 15, 16). It has 
the molecular weight of 29kD, which is equal to the sum of apoCaM (17kD) and 
GAP-43t (12kD). This coincidence indicates the protein complex was formed by 
apoCaM and GAP-43t with 1:1 molar ratio. Control experiment of GTA treatment of 
apoCaM alone (Fig. 16, Lane 4) and GAP-43t alone (Fig. 16, Lane 5) didn’t produce 
the 29kD new protein. This result confirms the 29kD protein we obtained is a product 
of apoCaM – GAP-43t binding and GTA crosslinking, but not self-linkage of 
apoCaM or GAP-43t. 
By comparison of different molar ratios of apoCaM and GAP-43t treated by 
GTA (Fig. 14, Lane 3, 4, 5 ; Fig.16, Lane 1, 2, 3), we demonstrated that 1:1 molar 
ratio of apoCaM and GAP-43t is the best combination for the formation of the protein 
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complex. This is consistent with our finding that the protein complex was formed by 
apoCaM and GAP-43t with 1:1 molar ratio. The 1:1 molar ratio is in accordance with 
the fact that GAP-43t only has one apoCaM-binding IQ motif, which determines the 
binding of apoCaM and GAP-43t in 1:1 molecule ratio.  
We also demonstrated that GTA crosslinking of apoCaM and GAP-43t acts in a 
time-dependent manner by comparison of different GTA treatment times (Fig. 15; 
Fig.16, Lane 6-9). However, GTA treatment longer than 120 min should be avoided 
as our results suggest it may cause heavy smears. 
The yield of the protein complex of apoCaM and GAP-43t was not satisfactory, 
which can be explained by following reasons. First, the binding of apoCaM and IQ 
motif is a weak binding, which was demonstrated by Cui et al. (Cui et al. 2003) in the 
NMR studies on the interaction between apoCaM and IQ motif of Neurogranin. As IQ 
motif is the apoCaM-binding domain of GAP-43t, the binding of apoCaM and 
GAP-43t is expected to be weak too. Second, apoCaM has a low amount of free 
lysine residues, while previous study (Silva et al. 2004) indicated the number of free 
lysine residues is crucial for GTA crosslinking. Therefore GTA crosslinking of 
apoCaM and GAP-43t was affected by the lack of free lysine residues in apoCaM. 
Lastly, opposite to apoCaM, GAP-43t has a high amount of free lysine residues. But 
besides its positive contribution to the GTA stabilization of the apoCaM – GAP-43t 
protein complex, the high amount of free lysine residues in GAP-43t also serves to 
increase the undesired GAP-43t self-linkage, which may compete with the binding of 
apoCaM and GAP-43t, and thus reduces the yield of the protein complex. 
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The protein complex of apoCaM and GAP-43t represents not only a protein 
complex of CaM and a GAP-43 derived peptide, but also a protein complex of 
apoCaM and an IQ motif peptide. Further studies on this protein complex will provide 
significant insights into both the CaM – GAP-43 interaction and the apoCaM – IQ 
motif interaction. 
 
4.5 Future works 
The protein complex of apoCaM and GAP-43t provides a new approach to the 
studies on both the CaM – GAP-43 interaction and the apoCaM – IQ motif interaction. 
Future works should be carried out based on this protein complex. 
a. To optimize the binding conditions of apoCaM and GAP-43t to achieve high 
yield and high purity of the protein complex for further studies. 
b. To purify the protein complex of apoCaM and GAP-43t and perform 
crystallization studies to obtain 3-D structure, which can be used to verify the 
theoretical model of apoCaM – IQ motif interaction shown in Fig. 3. The 
detailed structural information of this protein complex will also provide a 
structure interpretation on the CaM – GAP-43 interaction through IQ motif 
shown in Fig. 4. 
c. To perform mutation studies in IQ motif of GAP-43t to further investigate the 
interaction between apoCaM and IQ motif. Results of these studies will 
contribute to those studies on other proteins containing IQ motif as the 
apoCaM-binding domain. 
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d. To perform mutation studies on PKC phosphorylation site Ser41 of GAP-43t 
to further investigate the effects of PKC phosphorylation and 
dephosphorylation on the interaction between CaM and GAP-43. These 
studies will help to understand the PKC regulation on the CaM – GAP-43 
interaction shown in Fig. 4. 
e. To use full length GAP-43 to investigate the interaction between CaM and 
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